• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOVENTUS LLC DUROLANE PFS; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOVENTUS LLC DUROLANE PFS; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Patient Problem Insufficient Information (4580)
Event Date 04/25/2024
Event Type  malfunction  
Event Description
Spontaneous report.Insurance verification representative at mdo reported that the durolane medication leaked out of the pen, there was no seal or the seal was bad.Unknown if pt missed dose, if pt currently possesses defective device or if adverse event occurred.No further information provided.Reported to (b)(6) by: health professional.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUROLANE PFS
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
BIOVENTUS LLC
MDR Report Key19212631
MDR Text Key341539485
Report NumberMW5154428
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/29/2024
Patient Sequence Number1
Treatment
GENVOYA 150/150/200/10MG
Patient Age61 YR
Patient SexMale
-
-